NDC 87063-292 – Nabumetone

Nabumetone 750 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC87063-292

Product details

Brand name
Nabumetone
Generic name
Nabumetone
Labeler
ASCLEMED USA INC.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA078420
Marketed since
June 26, 2019
Listing expires
December 31, 2027
Pharmacologic class
Nonsteroidal Anti-inflammatory Drug

Active ingredients

Uses, dosage, side effects and warnings for Nabumetone →

Package NDC codes (8)

Package NDCDescriptionSince
87063-292-01100 TABLET in 1 BOTTLE (87063-292-01)Aug 19, 2026
87063-292-066 TABLET in 1 BOTTLE (87063-292-06)Aug 19, 2026
87063-292-077 TABLET in 1 BOTTLE (87063-292-07)Aug 19, 2026
87063-292-1010 TABLET in 1 BOTTLE (87063-292-10)Aug 19, 2026
87063-292-2020 TABLET in 1 BOTTLE (87063-292-20)Aug 19, 2026
87063-292-3030 TABLET in 1 BOTTLE (87063-292-30)Aug 19, 2026
87063-292-6060 TABLET in 1 BOTTLE (87063-292-60)Aug 19, 2026
87063-292-9090 TABLET in 1 BOTTLE (87063-292-90)Aug 19, 2026

Other Nabumetone products